← FDA Drug Approvals (Drugs@FDA)
TOBRAMYCIN AND DEXAMETHASONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS US · Approved 2022-02-11
Drug application
- FDA Application #
ANDA212715- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TOBRAMYCIN AND DEXAMETHASONE
- Generic name
- TOBRAMYCIN AND DEXAMETHASONE
- Active ingredients
- DEXAMETHASONE; TOBRAMYCIN
- Dosage form
- SUSPENSION/DROPS
- Route
- OPHTHALMIC
- Marketing status
- Prescription
- Sponsor
- PADAGIS US
- Manufacturer
- Padagis US LLC
- First approval
- 2022-02-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown